Get started

Ajantapharma

Ajanta Pharma (D): Bullish (Apex Squeeze & Pre-Breakout Setup)Timeframe: Daily | Scale: Linear Ajanta Pharma is coiled in a massive compression zone, tightly squeezing against key historical resistance levels. Backed by excellent quarterly earnings and strong institutional accumulation, the probability of an upside breakout is highly elevated. ๐Ÿš€ 1. The Fundamental Catalyst (The "Fuel") The rising volume and persistent upward pressure are directly linked to the recent Q4 performance: > Earnings Beat: Strong top-line and bottom-line growth confirms the company's operational strength. > Forward Guidance: Management's confident projection of 16โ€“18% revenue growth for FY27 gives institutional buyers the conviction to accumulate shares right at these resistance levels. ๐Ÿ“ˆ 2. The Chart Structure (The Triangle Squeeze) > The Convergence: The stock is forming a classic Triangle Pattern. The horizontal ceiling from Nov 2024 acts as a rigid supply zone, while the angular line from Sept 2024 is acting as dynamic support, pushing the price higher. > Today's Action: The 0.9% surge on 237.94K volume indicates that bulls are persistently knocking on the door of the Nov 2024 horizontal resistance. The lack of a violent rejection implies that the sellers at this level are gradually getting exhausted. ๐Ÿ“Š 3. Volume & Indicators Indicator analysis paints a picture of absolute trend harmony. > Trend Alignment: The Positive Crossover (PCO) in the short-term EMAs across the Monthly, Weekly, and Daily timeframes confirms that the broader macro trend remains firmly up. > Momentum: The rising RSI across all three timeframes indicates that underlying momentum is quietly building up before the actual price breakout occurs. > Volume Accumulation: The rising volume profile confirms that smart money is actively absorbing the overhead supply. ๐ŸŽฏ 4. Future Scenarios & Key Levels The stock is at a pivotal juncture. The price action in the coming days will dictate the next major swing. ๐Ÿ‚ Bullish Targets (The Breakout): - Trigger: A decisive Daily Close strictly above the Nov 2024 horizontal resistance zone (clearing the โ‚น3,110โ€“โ‚น3,150 supply area) backed by sustained heavy volume. - Target 1: โ‚น3,450 โ€“ โ‚น3,485. ๐Ÿ›ก๏ธ Support (The "Must Hold"): - Immediate Support: โ‚น2,950 โ€“ โ‚น3,000. If the breakout fails and momentum cools off, the stock should find immediate support near its short-term moving averages. - Invalidation: A close below the angular trendline would invalidate the bullish structure and signal a return to a broader consolidation phase.
NSE:AJANTPHARMLong
by Learn_with_Pth0mas
2
Ajanta Pharma Limited Daily Chart๐Ÿ“Š Current Price Approx LTP: โ‚น2,850 โ€“ โ‚น2,890 range on NSE daily chart. ๐Ÿ“ˆ Ajanta Pharma โ€” 1 Day Key Levels ๐Ÿ”น Pivot Point Pivot: โ‚น2,835.57 ๐Ÿ”น Resistance Levels R1: โ‚น2,883.13 R2: โ‚น2,913.57 R3: โ‚น2,961.13 ๐Ÿ”น Support Levels S1: โ‚น2,805.13 S2: โ‚น2,757.57 S3: โ‚น2,727.13 ๐Ÿ“‰ Moving Average Levels (Daily) 10-EMA: โ‚น2,888 20-EMA: โ‚น2,882 50-EMA: โ‚น2,865 100-EMA: โ‚น2,847 200-EMA: โ‚น2,820 ๐Ÿ‘‰ Price trading above most moving averages, showing short-term bullish momentum. ๐Ÿ“Š Momentum Indicators RSI: ~60 โ†’ bullish strength CCI: ~119 โ†’ strong upside momentum ADX: ~50 โ†’ strong trend present ๐ŸŽฏ Important Trading Zones Bullish breakout: Above โ‚น2,913 โ†’ target โ‚น2,960 โ€“ โ‚น3,000 Buy on dip zone: โ‚น2,800 โ€“ โ‚น2,830 Bearish breakdown: Below โ‚น2,755 โ†’ downside toward โ‚น2,720
NSE:AJANTPHARMLong
by GlobalWolfStreet
Ajanta Pharma at a Critical Point | Breakout or RejectionAjanta Pharma is currently trading around the โ‚น2800 mark, which has acted as a strong resistance zone over the past few months. The stock has tested this level 4 to 5 times, indicating significant supply pressure and trader interest at this price point. At this stage, Ajanta Pharma stands at a crucial inflection point: ๐Ÿ“ˆ Bullish Scenario: A clean breakout above โ‚น2800, especially with volume confirmation, could potentially lead to a 10% upside in the near term, with scope for a 20% rally if momentum sustains. ๐Ÿ“‰ Bearish Scenario: However, if the stock fails to break through and faces rejection again, we might see a pullback of around 10%, as traders book profits or short near resistance. This setup presents a high-reward trade opportunity with a well-defined risk level, making it a good candidate to keep on your watchlist. Disclaimer: This post is for educational and informational purposes only. I am not a SEBI-registered investment advisor or research analyst. Please do your own research or consult a certified financial advisor before making any investment decisions.
NSE:AJANTPHARMLong
by Chai_trades
AJANTA PHARMA LTDBuy Ajanta above: 3351 only. All important points are marked. ๐ƒ๐ข๐ฌ๐œ๐ฅ๐š๐ข๐ฆ๐ž๐ซ: ๐ˆ๐ง๐ฏ๐ž๐ฌ๐ญ๐ฆ๐ž๐ง๐ญ ๐ข๐ง ๐ฌ๐ž๐œ๐ฎ๐ซ๐ข๐ญ๐ข๐ž๐ฌ ๐ฆ๐š๐ซ๐ค๐ž๐ญ ๐š๐ซ๐ž ๐ฌ๐ฎ๐›๐ฃ๐ž๐œ๐ญ ๐ญ๐จ ๐ฆ๐š๐ซ๐ค๐ž๐ญ ๐ซ๐ข๐ฌ๐ค๐ฌ, ๐ซ๐ž๐š๐ ๐š๐ฅ๐ฅ ๐ญ๐ก๐ž ๐ซ๐ž๐ฅ๐š๐ญ๐ž๐ ๐๐จ๐œ๐ฎ๐ฆ๐ž๐ง๐ญ๐ฌ ๐œ๐š๐ซ๐ž๐Ÿ๐ฎ๐ฅ๐ฅ๐ฒ ๐›๐ž๐Ÿ๐จ๐ซ๐ž ๐ข๐ง๐ฏ๐ž๐ฌ๐ญ๐ข๐ง๐ . ๐’๐ญ๐จ๐œ๐ค๐ฌ ๐ฌ๐ฎ๐ ๐ ๐ž๐ฌ๐ญ๐ž๐ ๐ข๐ง ๐ญ๐ก๐ข๐ฌ ๐ ๐ซ๐จ๐ฎ๐ฉ ๐š๐ซ๐ž ๐Ÿ๐จ๐ซ ๐ž๐๐ฎ๐œ๐š๐ญ๐ข๐จ๐ง ๐ฉ๐ฎ๐ซ๐ฉ๐จ๐ฌ๐ž. ๐–๐ž ๐๐จ๐ง๐ญ ๐ฆ๐š๐ค๐ž ๐š๐ง๐ฒ ๐ฉ๐ซ๐จ๐Ÿ๐ข๐ญ๐ฌ ๐Ÿ๐ซ๐จ๐ฆ ๐ญ๐ก๐ข๐ฌ ๐ซ๐ž๐œ๐จ๐ฆ๐ฆ๐ž๐ง๐๐š๐ญ๐ข๐จ๐ง๐ฌ ๐ž๐ฏ๐ž๐ซ๐ฒ๐ญ๐ก๐ข๐ง๐  ๐ฌ๐ก๐š๐ซ๐ž๐ ๐ก๐ž๐ซ๐ž ๐š๐ซ๐ž ๐œ๐จ๐ฆ๐ฉ๐ฅ๐ž๐ญ๐ž๐ฅ๐ฒ ๐จ๐Ÿ ๐Ÿ๐ซ๐ž๐ž ๐จ๐Ÿ ๐œ๐จ๐ฌ๐ญ.
NSE:AJANTPHARMLong
by sreekumars
Ajanta Pharma looking good The stock has taken a support at 2175 around and can go upwards from here. Talking about fundamental analysis, the stock has a net profit margin which fluctuates between 15-20% on yearly basis which is good for investment. The revenue has been increasing continuously for the past 5 years and the net profit looks good too. Talking about the technical analysis, the stock is not in the overbought zone and has taken a support on the weekly chart itself. CMP 2311 Can be held for a medium to long term perspective. Note: This is not an investment advice, it is just an educational study from my perspective. I am not SEBI registered.
NSE:AJANTPHARMLong
by rokosbasilisk123
Swing Trading Opportunity in Ajanta PharmaRefer the chart for Entry,Target and SL. NOTE: This trade is only for Equity Swing buy and not to be considered for options trading. Please do follow Position Sizing and Risk Reward Ratio while planning any trades. Note: This information is for education purpose only and please do your own research and consult your financial advisor prior to taking any action. TO CONNECT WITH ME CHECK OUT MY BIO. If you like this Idea, Please do like my ideas and share it with your friends. check my bio. Please boost my ideas and send cheers as it acts as a motivation to keep posting my analysis. Thank you
NSE:AJANTPHARMLong
by rkinspiro1
Go Long with Ajanta Pharma for swing trade Aggressive Traders can go long with Ajanta Pharma at CMP around 1300 with SL around 1250-1260 and target 1330, 1400 and final target around 1440-1460. It may consolidate near 1460 for few days before next move. Conservative traders should enter near 1190, if get chance, with SL around 1140. Target depends on next price action. Same targets can be considered if major selling pressure is not seen before reaching to entry point (1190). DISCLAIMER:- I'm not SEBI Registered. Ideas shared here are my personal view and not to take trades, these are for educational purpose only. Please consult your investment/trading advisor before taking any position.
NSE:AJANTPHARMLong
by anilpatidar